null Earl Rubin, MD

Associate Investigator, RI-MUHC

Infectious Diseases and Immunity in Global Health Program

Associate Professor, Department of Pediatrics, Faculty of Medicine and Health Sciences, McGill University

Department of Pediatrics, Division of Infectious Diseases, MUHC



vaccine development

Research Focus

My research focuses on industry sponsored trials of vaccines.

Selected Publications

Click on Pubmed to see my current publications list

  • Barton M, O Brien K, Robinson JL, Davies DH, Simpson K, Asztalos E, Langley JM, Le Saux N, Sauve R, Synnes A, Tan B, de Repentigny L, Rubin E, Hui C, Kovacs L, Richardson SE. Invasive candidiasis in low birth weight preterm infants: risk factors, clinical course and outcome in a prospective multicenter study of cases and their matched controls. BMC Infect Dis. 2014 Jun 12;14(1):327.

  • P. Bhuyan, MD, PhD A.W. Lee, MD, M. Li, A. Tomovici, MD. Safety and Immunogenicity of a Toddler Dose Following an Infant Series of a Hexavalent Diphtheria, Tetanus, Acellular Pertussis, Inactivated Poliovirus, Haemophilus influenzae type b, Hepatitis B Vaccine Administered Concurrently or at Separate Visits With a Heptavalent Pneumococcal Conjugate Vaccine. The Pediatric Infectious Disease Journal 01/2014:33(1);73-80 PMID: 24346596.

  • Bruce Tapiero, Scott A. Halperin, William Meekison, Francisco Diaz-Mitoma, Paul Zickler, Earl Rubin, Joanne Embree, , Prakash Bhuyan, , Andrew Wen-Tseng Lee, Minran Li, Antigona Tomovici, MD. Safety and Immunogenicity of Hexavalent Vaccine Administered at 2, 4 and 6 Months of Age With or Without a Heptavalent Pneumococcal Conjugate Vaccine (PCV7): A Randomized, Open-Label Study, The Pediatric Infectious Disease Journal 01/2013:32(1):54-61 PMID: 23241989.